The article discusses management of a female patient with chronic heart failure with reduced left ventricular ejection fraction after an episode of acute decompensation. Replacing an angiotensin-converting enzyme inhibitor with a representative of a new angiotensin receptor-neprilysin inhibitor class, sacubitril/valsartan, in the combination therapy allowed fast achievement and maintenance of the compensation state. The treatment was well tolerated and was not associated with clinically significant adverse effects.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
female patient
8
[experience hospital
4
hospital initiation
4
initiation sacubitril/valsartan
4
sacubitril/valsartan female
4
patient acute
4
acute decompensated
4
decompensated heart
4
heart failure]
4
failure] article
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!